Novel anticoagulants agents may provide lower risk of intraocular hemorrhage

Novel antithrombotic pose an equal or lower risk of intraocular hemorrhage than their traditional counterparts, according to this analysis of insurance claims. 

Study design

This retrospective cohort study analyzed the safety profiles of novel anticoagulants and antiplatelet therapy. Investigators analyzed the incidence of intraocular hemorrhage between months 3 and 12 among new users of antithrombotic drugs.


A statistical comparison of 146,137 patients taking warfarin....Continue reading


How We Get Them & How We Get Rid Of Them

Do you have something that looks like a pimple on the outside or inside your eyelid? Is it terribly uncomfortable and unsightly?  You either have a stye or a chalazion on your eye.  

Chalazion is a non-infected swelling of the lid caused by a blocked lipid gland. Lipid from the blocked gland leaks into the eye lid tissue causing an inflammation which eventually clears the irritating lipid. This can take 2 to 4 weeks or more.

St....Continue reading

Baseline BCVA superior to OCT biomarkers for predicting vision outcomes in wet AMD

Investigators evaluated the potential of machine learning to predict vision outcomes from baseline assessments of patients receiving ranibizumab for neovascular AMD.

Study design

This post hoc analysis of prospective trial data included 614 patients receiving monthly or PRN ranibizumab for wet AMD. Monthly OCT volume scans were processed by a fully automated computational image analysis capable of detecting intraretinal cystoid fluid (IRF), subretinal fluid (SRF) and pigment epithelial....Continue reading

Page 1 of 212

© Copyright Lehigh Valley Center For Sight